These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1099 related articles for article (PubMed ID: 6205623)
1. Estrogen and progesterone receptors in melanoma metastases with special reference to analytical methods and prognosis. Fernö M; Borg A; Erichsen C; Ingvar C; Jönsson PE Anticancer Res; 1984; 4(3):179-82. PubMed ID: 6205623 [TBL] [Abstract][Full Text] [Related]
2. Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer. Norgren A; Borg A; Fernö M; Johansson U; Lindahl B; Tsiobanelis K Anticancer Res; 1982; 2(5):315-20. PubMed ID: 6187272 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151 [TBL] [Abstract][Full Text] [Related]
4. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method]. Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620 [TBL] [Abstract][Full Text] [Related]
5. The nontransformed progesterone and estrogen receptors in gastric cancer. Wu CW; Chang HM; Kao HL; Lui WY; P'eng FK; Chi CW Gastroenterology; 1992 May; 102(5):1639-46. PubMed ID: 1373695 [TBL] [Abstract][Full Text] [Related]
6. A comparison of two steroid receptor assays in breast cancer: dextran coated charcoal and isoelectric focusing. Fernö M; Borg A; Norgren A Anticancer Res; 1983; 3(4):243-6. PubMed ID: 6192752 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method. Thorpe SM Cancer Res; 1987 Dec; 47(24 Pt 1):6572-5. PubMed ID: 2445474 [TBL] [Abstract][Full Text] [Related]
8. Measurement of nuclear estrogen receptors by charcoal adsorption: relationships of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer. Nishimura R; Kimura M; Tokunaga T; Akagi M Gan; 1982 Oct; 73(5):713-20. PubMed ID: 6187619 [TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma. Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417 [TBL] [Abstract][Full Text] [Related]
10. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels. Di Fronzo G; Coradini D; Cappelletti V; Miodini P; Granata G; Schwartz M; Panko WB Anticancer Res; 1990; 10(6):1699-705. PubMed ID: 2285244 [TBL] [Abstract][Full Text] [Related]
11. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788 [TBL] [Abstract][Full Text] [Related]
12. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer. Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898 [TBL] [Abstract][Full Text] [Related]
13. [Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma]. Simone G; Paradiso A; Cirillo R; Mangia A; Rella G; Wiesel S; Petroni S; De Benedictis G; De Lena M Pathologica; 1991; 83(1086):449-59. PubMed ID: 1724316 [TBL] [Abstract][Full Text] [Related]
14. Progesterone receptor in hepatocellular carcinoma. Correlation with androgen and estrogen receptors. Nagasue N; Kohno H; Yamanoi A; Kimoto T; Chang YC; Nakamura T Cancer; 1991 May; 67(10):2501-5. PubMed ID: 1849788 [TBL] [Abstract][Full Text] [Related]
15. Comparison of dextran-coated charcoal and sucrose density gradient analyses of estrogen and progesterone receptors in human breast cancer. Anderson KM; Bonomi P; Marogil M; Hendrickson C; Economou S Cancer Res; 1980 Nov; 40(11):4127-32. PubMed ID: 6162545 [No Abstract] [Full Text] [Related]
16. Steroid receptors in a group of Brazilian melanoma patients. Belizário JE; Santos IO; Brentani MM Braz J Med Biol Res; 1984; 17(1):21-6. PubMed ID: 6478095 [TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptor analyses in more than 4,000 human breast cancer samples. A study with special reference to age at diagnosis and stability of analyses. Southern Swedish Breast Cancer Study Group. Fernö M; Borg A; Johansson U; Norgren A; Olsson H; Rydén S; Sellberg G Acta Oncol; 1990; 29(2):129-35. PubMed ID: 2334566 [TBL] [Abstract][Full Text] [Related]
18. Determination of estrogen and progesterone receptors in endometrial adenocarcinomas. Comparison between dextran-coated charcoal and immunoenzymatic methods on curettage biopsies. Marchal S; Marchal C; Hoffstetter S; Parache RM; Pernot M Anticancer Res; 1992; 12(4):1307-10. PubMed ID: 1380228 [TBL] [Abstract][Full Text] [Related]
19. Steroid receptors in human endometrium. Comparison of data obtained by three different methods. Utaaker E; Iversen OE; Segadal E Int J Biochem; 1983; 15(9):1179-82. PubMed ID: 6617961 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors. Macías A; Pascual MR; Pérez R; Lage A Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]